Endothelin-induced changes in blood flow in STZ-diabetic and non-diabetic rats: Relation to nitric oxide synthase and cyclooxygenase inhibition

Journal of Physiological Sciences

Volumn 61, Issue 6, 2011, Pages 497-505

  Granstam, Sven Olof ^a,b   Granstam, Elisabet ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Blood flow; Diabetes mellitus; Endothelin; Nitric oxide; Rat

Indexed keywords

CYCLO(TRP ASP PRO VAL LEU); CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; ENDOTHELIN 1; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; HEMODYNAMICS; METABOLISM; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; VASOCONSTRICTION; VASODILATATION;

ANIMALS; BLOOD PRESSURE; CYCLOOXYGENASE INHIBITORS; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIN-1; HEMODYNAMICS; INDOMETHACIN; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEPTIDES, CYCLIC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; VASOCONSTRICTION; VASODILATION;

EID: 84855988187     PISSN: 18806546     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12576-011-0171-x     Document Type: Article

References (39)

1. Wong WT, Wong SL, Tian XY, Huan Y (2010) Endothelial dysfunction: the common consequence in diabetes and hypertension. J Cardiovasc Pharmacol 55:300-307
2. Yanagisawa M, Inoue A, Ishikawa T, Kasuya Y, Kimura S, Kumagaye S, Nakajima K, Watanabe T, Sakaibara S, Goto K, Msaki T (1988) Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci USA 85:6964-6967
3. Sud N, Black SM (2009) Endothelin-1 impairs nitric oxide signaling in endothelial cells through a protein kinase C deltadependent activation of STAT3 and decreased endothelial nitric oxide synthase expression. DNA Cell Biol 28:543-553
4. Ivey ME, Osman N, Little PJ (2008) Endothelin-1 signaling in vascular smooth muscle: pathways controlling cellular functions associated with atherosclerosis. Atherosclerosis 199:237-247
5. Khan ZA, Chakrabarti S (2007) Cellular signaling and potential new treatment targets in diabetic retinopathy. Exp Diabetes Res 2007:31867-31879
6. Sachidanandam K, Portik-Dobos V, Kelly-Cobbs AI, Ergul A (2010) Dual endothelin receptor antagonism prevents remodeling of resistance arteries in diabetes. Can J Physiol Pharmacol 88:616-621
7. Ak G, Buyukberger S, Sevinc A, Turk HM, Ates M, Sari R, Savli H, Cigli A (2001) The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with type 2 diabetes mellitus. J Diabetes Complicat 15:150-157 (Pubitemid 32453172)
8. Roldán-Pallarés M, Rollin R, Martinez-Montero JC, Fernández-Cruz A, Bravo-Llata C, Fernández-Durango R (2007) Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinoapthy. Retina 27:222-235
9. De Mattia G, Cassone-Faldetta M, Bellini C, Bravi MC, Laurenti O, Baldoncini R, Santucci A, Ferri C (1998) Role of plasma and urinary endothelin-1 in early diabetic and hypertensive nephropathy. Am J Hypertens 11:983-988 (Pubitemid 28378413)
10. Zanatta CM, Gerchman F, Burttet L, Nabinger G, Jacques-Silva MC, Canani LH, Gross JL (2008) Endothelin-1 levels and albuminura in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 80:299-304
11. Rubanyi GM, Polokoff MA (1994) Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46:325-415
12. Böhm F, Pernow J (2007) The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 76:8-18 (Pubitemid 47362047)
13. Makino A, Kamata K (1998) Elevated plasma endothelin-1 level in streptozotocin-induced diabetic rats and responsiveness of the mesenteric arterial bed to endothelin-1. Br J Pharmacol 123:1065-1072 (Pubitemid 28120501)
14. Chakrabarti S, Sima AA (1997) Endothelin-1 and endothelin-3- like immunoreactivity in the eyes of diabetic and non-diabetic BB/W rats. Diabetes Res Clin Pract 37:109-120 (Pubitemid 27345250)
15. Sasser JM, Sullivan JC, Hobbs JL, Yamamoto T, Pollock DM, Carmines PK, Pollock JS (2007) Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism. J Am Soc Nephrol 18:143-154 (Pubitemid 46053429)
16. Hillerdal M (1987) Cochlear blood flow in the rat: a methodological evaluation of the microspere method. Hear Res 27:27-35 (Pubitemid 17061873)
17. Granstam S-O, Lind L, Granstam E, Fellström B (1998) Effects of nitric oxide synthase inhibition and endothelin ETA receptor blockade on haemodynamics in hypertensive rats. Clin Exp Pharmacol Physiol 25:693-701 (Pubitemid 28399065)
18. Granstam E, Granstam S-O (1999) Regulation of uveal and retinal blood flow in STZ-diabetic and non-diabetic rats; involvement of nitric oxide. Curr Eye Res 19:330-337
19. Srinivasan K, Ramarao P (2007) Animal models in type 2 diabetes research: an overview. Indian J Med Res 125:451-472 (Pubitemid 46805458)
20. Granstam E, Granstam S-O (2003) Involvement of nitric oxide in the regulation of regional hemodynamics in streptozotocin-diabetic rats. Physiol Res 52:159-169 (Pubitemid 36427818)
21. Song D, Yao R, Pang CC (2008) Altered vasodilator role of nitric oxide synthase in the pancreas, heart and rain of rats with spontaneous type 2 diabetes. Eur J Pharmacol 591:177-181
22. Dorner GT, Garhöfer G, Selenko N, Fasching P, Baverle-Eder M, Schmetterer L, Wolzt M (2003) The ocular hemodynamic response to nitric oxide synthase inhibition is unaltered in patients with early type I diabetes. Graefes Arch Clin Exp Ophthalmol 241:619-624 (Pubitemid 37121105)
23. Matsumoto T, Ishida K, Nakayama N, Kobayashi T, Kamata K (2009) Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat. Am J Physiol Heart Circ Physiol 296:H1388-H1397
24. Bender SB, Kalubunde RE (2007) Altered role of smooth muscle endothelin recetpors in coronary endothelin-1 and alpha1-adrenoceptor- mediated vasoconstriction in type 2 diabetes. Am J Physiol Heart Circ Physiol 293:H2281-H2288 (Pubitemid 47605872)
25. Feng J, Liu Y, Khabbaz KR, Hagberg R, Robich MP, Clements RT, Bianchi C, Sellke FW (2011) Decreased contractile response to endothelin-1 of peripheral microvasculature from diabetic patients. Surgery 149(2):247-252
26. Jesmin S, Zaedi S, Meada S, Yamaguchi I, Goto K, Miyauchi T (2006) Effects of a selective endothelin A receptor antagonist on the expressions of iNOS and eNOS in the heart of early streptozotocin- induced diabetic rats. Exp Biol Med 231:925-931 (Pubitemid 43845554)
27. Bill A, Sperber G, Ujile K (1983) Physiology of the choroidal vascular bed. Int Ophthalmol 6:101-107 (Pubitemid 13165004)
28. Nickla DL, Wallman J (2010) The multifunctional choroid. Prog Retin Eye Res 29:144-168
29. Delgado E, Marques-Neves C, Rocha I, Sales-Luis J, Silva- Carvalho L (2010) Endothelin-1 effects on spontaneous oscillations in choroidal arterioles. Acta Ophthalmol 88:742-747
30. Kiel JW (2000) Endothelin modulation of choroidal blood flow in the rabbit. Exp Eye Res 71(6):543-550 (Pubitemid 32002240)
31. Sato T, Takei K, Nonyama T, Miyauchi T, Goto K, Hommura S (1995) Increase in choroidal blood flow in rabbits with endothelin- 1 induced transient complete obstruction of retinal vessels. Graefes Arch Clin Exp Ophthalmol 233(7):425-429
32. De Juan JA, Moya FJ, Fernandez-Cruz A, Fernandez-Durango R (1995) Identification of endothelin receptor subtypes in rat retina using subtype-selective ligands. Brain Res 690(1):25-33
33. Hirose A, Azuma H, Tokoro T, Hirai K (2007) Endothelin-B receptors on suprachoroidal melanocytes mediate an endothelin- 1-induced increase in the intracellular calcium concentration of rabbit ocular suprachoroidal tissue. Curr Eye Res 32(6):585-591 (Pubitemid 47035870)
34. Oku H, Kida T, Sugiyama T, Hamada J, Sato B, Ikeda T (2001) Possible involvement of endothelin-1 and nitric oxide in the pathogenesis of proliferative diabetic retinopathy. Retina 21:647-651 (Pubitemid 34027780)
35. Deng D, Evans T, Mukherjee K, Downey D, Chakrabarti S (1999) Diabetes-induced vascular dysfunction in the retina: role of endothelins. Diabetologia 42(10):1228-1234 (Pubitemid 29459820)
36. Chakrabarti S, Gan XT, Merry A, Karmazyn M, Sima AA (1998) Augmented retinal endothelin-1, endothelin-3, endothelinA and endothelinB gene expression in chronic diabetes. Curr Eye Res 17(3):301-307 (Pubitemid 28138278)
37. Wu Y, Feng B, Chen S, Zuo Y, Chakrabarti S (2010) Glucoseinduced endothelin-1 expression is regulated by ERK5 in the endothelial cells and retina of diabetic rats. Can J Physiol Pharmacol 88(6):607-615
38. Descorbeth M, Anand-Srivastava MB (2010) Role of vasoactive peptides in high glucose-induced increased expression of Gaq/11 proteins and associated signaling in vascular smooth muscle cells. Can J Physiol Pharmacol 88(3):331-340
39. Vanhoutte PM, Shimokawa H, Tang EHC, Feletou M (2009) Endothelial dysfunction and vascular disease. Acta Physiol 196:193-222